Blog
RSS FeedPosted by Michael Wonder on 18 Dec 2021
PHARMAC bundle deal life-giving for some cancer patients, but medics say NZ still 'playing catch up' for best treatments
16 December 2021 - About 100 patients with stage 3 lung cancer stand to gain extra years of life from ...
Posted by Michael Wonder on 16 Dec 2021
PHARMAC looking to fund medicines for lung and ovarian cancer
16 December 2021 - PHARMAC is considering funding a bundle deal which would give New Zealanders more effective treatment options for ...
Posted by Michael Wonder on 14 Dec 2021
PHARMAC still stalled on lung cancer drug
14 December 2021 - Lung cancer sufferers are still waiting on PHARMAC to reverse a decision made more than a ...
Posted by Michael Wonder on 12 Dec 2021
Where to now for PHARMAC?
10 December 2021 - The interim report of the review of PHARMAC has just been published, with the thrust of ...
Posted by Michael Wonder on 08 Dec 2021
Funding Keytruda for melanoma but not for lung cancer is racist, health advocates say
8 December 2021 - PHARMAC has been accused of institutional racism and breaching the Treaty of Waitangi for funding drugs ...
Posted by Michael Wonder on 07 Dec 2021
Critics blame diabetes deaths on PHARMAC taking years to fund new drug
6 December 2021 - Diabetes Foundation Aotearoa says PHARMAC's delay funding new diabetes drugs has led to many deaths in Māori ...
Posted by Michael Wonder on 07 Dec 2021
Shining a light on PHARMAC
6 December 2021 - It is encouraging to read the country’s drug buying agency PHARMAC is already moving to improve ...
Posted by Michael Wonder on 06 Dec 2021
PHARMAC negotiates deal with Pfizer for its promising new oral antiviral treatment for COVID-19
6 December 2021 - PHARMAC has negotiated an agreement with Pfizer for its promising new oral anti-viral treatment to treat ...
Posted by Michael Wonder on 02 Dec 2021
PHARMAC in review (2021) - part 2
3 December 2021 - As expected, the interim report fails to address the elephant in the room. ...
Posted by Michael Wonder on 02 Dec 2021
PHARMAC review: 'Damning' interim report reveals 'fortress mentality', Māori, equity progress slow
2 December 2021 - An interim report of a major PHARMAC review has slated the Government drug buying agency over ...
Posted by Michael Wonder on 02 Dec 2021
PHARMAC welcomes interim report
2 December 2021 - PHARMAC accepts many of the observations made in the Interim Report and is already making changes ...
Posted by Michael Wonder on 01 Dec 2021
PHARMAC in review (2021)
2 December 2021 - Another dismal year in terms of the number of new medicines listed in the New Zealand ...
Posted by Michael Wonder on 30 Nov 2021
New Zealand Pharmaceutical Schedule - 1 December 2021
1 December 2021 - The December 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 25 Nov 2021
PHARMAC publishes minutes of August 2021 PTAC meeting
25 November 2021 - Another sparse meeting in terms of the number of new funding applications and funding applications for ...
Posted by Michael Wonder on 16 Nov 2021
PHARMAC widens access to adalimumab through transition to biosimilar
17 November 2021 - Pharmac’s chief medical officer Dr David Hughes has today announced the decision to fund a biosimilar adalimumab ...